These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1178922)

  • 81. [Elaboration of live measles vaccine technology on human embryo lung diploid cell culture L-68].
    Nechaeva EA; Kolokol'tsova TD; Kits IV; Zhilina NV; Sen'kina TIu; Usova SV; Iurchenko ND; Azaev MSh; Tsareva AA
    Vestn Ross Akad Med Nauk; 1998; (3):29-32. PubMed ID: 9608273
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The problem of measles virus response with reference to vaccine viability, age, protein energy malnutrition and malaria in the tropics.
    Kimati VP; Loretu K; Munube GM; Kimboi F
    J Trop Pediatr; 1981 Aug; 27(4):205-9. PubMed ID: 6793733
    [No Abstract]   [Full Text] [Related]  

  • 83. Persistence of measles antibody after immunization.
    Domorázková E; Drevo M
    J Biol Stand; 1975; 3(2):225-30. PubMed ID: 1126966
    [No Abstract]   [Full Text] [Related]  

  • 84. Serological survey of measles virus infection in children in Pondicherry area.
    Bhau LN; Madhavan HN; Agarwal SC
    Indian J Med Res; 1979 Apr; 69():634-8. PubMed ID: 457205
    [No Abstract]   [Full Text] [Related]  

  • 85. Failure of attenuated viral vaccine in prevention of atypical measles.
    Chatterji M; Mankad V
    JAMA; 1977 Dec; 238(24):2635. PubMed ID: 579203
    [No Abstract]   [Full Text] [Related]  

  • 86. [Measles vaccination].
    Huisman J
    Ned Tijdschr Geneeskd; 1975 Apr; 119(17):671-3. PubMed ID: 1143549
    [No Abstract]   [Full Text] [Related]  

  • 87. Separating the factors in measles vaccine failure.
    Ekunwe EO
    Ann Trop Paediatr; 1985 Jun; 5(2):103-6. PubMed ID: 2409903
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sensitivity of immune adherence haemagglutination in detection of measles antibody in vaccinated and naturally immune individuals.
    Rapicetta M; D'Ambrosio E; Rozera C; Balducci L; Magliola E
    J Biol Stand; 1981 Oct; 9(4):373-8. PubMed ID: 7320020
    [No Abstract]   [Full Text] [Related]  

  • 89. [Measles].
    Gasnier JL
    Soins; 1979 May; 24(10):3-9. PubMed ID: 256636
    [No Abstract]   [Full Text] [Related]  

  • 90. [Antibodies to measles virus among the urban and rural population of the Andizhan Region].
    Klots VI; Babaiants RA; Niiazmatov BI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):115-6. PubMed ID: 6449812
    [No Abstract]   [Full Text] [Related]  

  • 91. Malnutrition and seroconversion following measles immunization.
    Ekunwe EO
    J Trop Pediatr; 1985 Dec; 31(6):290-1. PubMed ID: 3937902
    [No Abstract]   [Full Text] [Related]  

  • 92. Measles antibody in pregnant Argentinian women relative to vaccine-induced immunity and natural infection.
    Nates SV; Cumino A; Isa MB; Martínez LC; Naretto E; Medeot SI; Giordano MO; de Wolff CD
    Pediatr Infect Dis J; 1999 Oct; 18(10):937-9. PubMed ID: 10530595
    [No Abstract]   [Full Text] [Related]  

  • 93. Letter: Antibodies to poliovirus and measles virus.
    Witte JJ
    Can Med Assoc J; 1976 Mar; 114(5):412. PubMed ID: 175911
    [No Abstract]   [Full Text] [Related]  

  • 94. Long-term persistence of antibody following Enders' original and More attenuated live measles virus vaccine.
    Buynak EB; Weibel RE; Mclean AA; Hilleman MK
    Proc Soc Exp Biol Med; 1976 Dec; 153(3):441-3. PubMed ID: 1013156
    [No Abstract]   [Full Text] [Related]  

  • 95. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.
    Scott TF; Bonanno DE
    N Engl J Med; 1967 Aug; 277(5):248-50. PubMed ID: 6029312
    [No Abstract]   [Full Text] [Related]  

  • 96. Novel strategies for an effective measles vaccination programme under field conditions.
    Arya SC
    Vaccine; 1993; 11(3):391. PubMed ID: 8447166
    [No Abstract]   [Full Text] [Related]  

  • 97. [Immunofluorescence reaction in studying humoral immunity in parotitis].
    Iakovleva GS; Kaptsova TI; Bogomolova NN; Gordienko NM; Boriskin IuS
    Vopr Virusol; 1985; 30(4):488-91. PubMed ID: 3904211
    [No Abstract]   [Full Text] [Related]  

  • 98. Measles serology in children with a history of measles in early life.
    Adjaye N; Azad A; Foster M; Marshall WC; Dunn H
    Br Med J (Clin Res Ed); 1983 May; 286(6376):1478. PubMed ID: 6405849
    [No Abstract]   [Full Text] [Related]  

  • 99. Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.
    van den Hof S; Berbers GA; de Melker HE; Conyn-van Spaendonck MA
    Vaccine; 1999 Dec; 18(9-10):931-40. PubMed ID: 10580207
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.